• Contact Us
  • Submit RFI/RFP
  • Trust Center
  • Ethics Hotline (report a violation)
  • LIFE SCIENCES
  • HEALTHCARE
  • RESOURCES
    • The Future Prescription
    • Blog
    • Case Studies & Publications
    • Events
    • Press Releases
  • ABOUT
    • Leadership
    • Board of Directors
    • Our Vision and Mission
    • Careers
    • Locations
  • SIGN IN
    • TriNetX LIVE™
    • EVIDEX®
  • Trial Design
  • Datasets & Analytics
  • Non-US Oncology
  • RWE Generation
  • Drug Safety

Racial and ethnic disparities in the research and care of hereditary angioedema patients in the United States

Aug 3, 2023

Ravulizumab and eculizumab reduce transfusions in adult patients with paroxysmal nocturnal hemoglobinuria: evidence from three real-world databases: TriNetX us EMR, TriNetX US claims and Komodo Health

Ravulizumab and eculizumab reduce transfusions in adult patients with paroxysmal nocturnal hemoglobinuria: evidence from three real-world databases: TriNetX us EMR, TriNetX US claims and Komodo Health

Aug 3, 2023

Changes in hemoglobin measures observed in PNH patients treated with both c5 inhibitors ravulizumab and eculizumab: real-world evidence from a US-Based EMR network

Changes in hemoglobin measures observed in PNH patients treated with both c5 inhibitors ravulizumab and eculizumab: real-world evidence from a US-Based EMR network

Aug 3, 2023

Real-world healthcare utilization and clinical markers preceding dialysis in patients with primary hyperoxaluria (PH) in the United States (PO1317)

Real-world healthcare utilization and clinical markers preceding dialysis in patients with primary hyperoxaluria (PH) in the United States (PO1317)

Aug 3, 2023

Influence of hypertension on open aortic repair outcomes in patients with Marfan syndrome (PC042)

Influence of hypertension on open aortic repair outcomes in patients with Marfan syndrome (PC042)

Aug 3, 2023

Next Entries »

SOLUTIONS

Clinical Trial Design & Optimization

Data Sets & Analytics

Non-US Oncology

Insights & Evidence Generation

Drug Safety & Pharmacovigilance

WHO WE SERVE

Life Sciences

Healthcare Organizations

RESOURCES

Explore TriNetX RWD

Conferences

Webinars

Publications

Case Studies

ENTERPRISE

Leadership

Board of Directors

Careers

Locations

EMAIL OPT-IN

Get the latest on product updates, services, events, expert insights, and top industry trends.

Subscribe now

ABOUT TRINETX, LLC

TriNetX operates the world’s broadest federated network of real-world data in partnership with healthcare providers and applies intelligence that accelerates innovation across the healthcare ecosystem. Through its self-service, HIPAA-, GDPR-, and LGPD-compliant platform of federated deidentified and anonymous electronic health record datasets and consulting partnerships, TriNetX empowers its global community to improve clinical trial protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation.

TriNetX, LLC complies with all applicable privacy laws. For more information please visit our Trust Center.

FOLLOW US

LinkedIn
© TriNetX, LLC All Rights Reserved.
Terms of Use
Privacy & Cookies
Do not sell or share my personal information